Bildkälla: Stockfoto

Medivir: Tango Phase I Ready - Redeye

Today, Medivir communicated that its Partner Tango Therapeutics has received the approval to start a phase I/II study of TNG348. We update our likelihood of approval for the project.

Today, Medivir communicated that its Partner Tango Therapeutics has received the approval to start a phase I/II study of TNG348. We update our likelihood of approval for the project.
Börsvärldens nyhetsbrev
ANNONSER